HOUSTON, July 11, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that Founder and Chief Executive Officer, Pete O’Heeron, will present at the Advanced Wound Care Summit USA in Boston, Massachusetts, on July 15, 2025. The presentation will include recent research advances using fibroblast-based technology for indications such as wound healing and psoriasis.
Over 8,000 global entrepreneurs gather in Penang for five days of wellness innovation and mentorship.
HONG KONG, July 11, 2025 /PRNewswire/ -- QNET kicked off...
BOULDER, Colo., July 10, 2025 /PRNewswire/ -- The American Solar Energy Society (ASES) invites you to join SOLAR 2025: Innovation for Universal Renewable Energy...
SHANGHAI, July 10, 2025 /PRNewswire/ -- TCL CSOT, a global leader in advanced display technologies, participated in the Lenovo Tianxi AI Ecosystem Spring Launch...
Travelers can take advantage of expanded availability and seamless rail access to Comic-Con, Del Mar Races, Disneyland's 70th Celebration and more
ORANGE, Calif., July 9,...
Celebrating the bold leaders shaping the future through the world's most ground-breaking companies
WEST VALLEY, Utah, July 9, 2025 /PRNewswire/ -- Ernst & Young LLP...
Additionally, the companies expanded their photovoltaic module R&D collaboration focused on optimizing performance of utility-scale solar
LOS ALAMOS, N.M., July 9, 2025 /PRNewswire/ -- UbiQD®, a...
Reduced fast charge time, improved reliability and remote control via app
SHENZHEN, China, July 9, 2025 /PRNewswire/ -- DJI, the global leader in civilian drones...
As Consumers Search for the Best Non-Prescription Eye Supplements in 2025, Visium Pro Highlights Clean Label Formulation, GMP Manufacturing, and Ingredient Transparency for Digital Eye Strain and Screen Fatigue Support
As Consumers Search for the Best Non-Prescription Eye Supplements in 2025, Visium Pro Highlights Clean Label Formulation, GMP Manufacturing, and Ingredient Transparency for Digital Eye Strain and Screen Fatigue Support
THORNTON, Colo., July 08, 2025 (GLOBE NEWSWIRE) -- Ascent Solar Technologies (“Ascent” or the “Company”) (Nasdaq: ASTI), the leading U.S. innovator in the design and manufacturing of featherweight, flexible thin-film photovoltaic (PV) solutions, today commented on its commercial progress and solar material development in the first half of 2025, as the Company looks ahead to continued growth and advancement in the second half of the year.
Over 70 Speakers Including Illinois Governor JB Pritzker, IBM CEO Arvind Krishna, NYU Professor Scott Galloway and Technology Journalist David Pogue to Take Part in...